Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMT in Cystitis Glandularis Patients With Pelvic Lipomatosis
NCT07530627Phase 1Completed
- Sponsor
- Peking University First Hospital
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in cystitis glandularis and pelvic lipomatosis (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Symptom Response Assessed by >=50% Reduction in Interstitial Cystitis Symptom Index at 12 weeks. Started Feb 2025; status: completed.
02
Conditions
cystitis glandularispelvic lipomatosis
Beyond the preview
Go deeper on NCT07530627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07530627.